Allucent

📍 Cary, United States👥 970 employees💰 Last funded Sep 2025
Pharmaceutical Manufacturing🌐 Allucent.com
Website LinkedIn
Allucent is on a mission to help bring new therapies to light by solving the distinct challenges of small and mid-sized biotech companies. The company is purpose-built through the convergence of leading providers to address this unmet need. Today, Allucent is a global provider of comprehensive drug development solutions, including consulting, clinical operations, biometrics and clinical pharmacology across a variety of therapeutic areas. With more than 30 years of experience in over 60 countries, Allucent’s individualized partnership approach provides experience-driven insights and expertise to assist its clients in successfully navigating the complexities of delivering novel treatments to patients.
2
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in Allucent?
Allucent has 2 investors on record on gritt.io.
When did Allucent last raise funding?
The most recent investment in Allucent recorded on gritt.io was in September 2025.
What industry is Allucent in?
Allucent operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Allucent based?
Allucent is headquartered in Cary, United States.